Interferon-α: alternative first- or second-line therapeutic option for polycythaemia vera

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Access to Document

@article{78b4f45e6a124618839c75bf4bde9f45,

title = "Interferon-α: alternative first- or second-line therapeutic option for polycythaemia vera",

author = "John Mascarenhas",

year = "2020",

month = mar,

doi = "10.1016/S2352-3026(19)30252-2",

language = "English",

volume = "7",

pages = "e178--e179",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "3",

}

TY - JOUR

T1 - Interferon-α

T2 - alternative first- or second-line therapeutic option for polycythaemia vera

AU - Mascarenhas, John

PY - 2020/3

Y1 - 2020/3

UR - http://www.scopus.com/inward/record.url?scp=85079833151&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(19)30252-2

DO - 10.1016/S2352-3026(19)30252-2

M3 - Comment/debate

C2 - 32014126

AN - SCOPUS:85079833151

SN - 2352-3026

VL - 7

SP - e178-e179

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 3

ER -